National Drug and Alcohol Research Centre. (2022) 2022 NDARC annual research symposium: spotlight presentations. NDARC.
External website: https://ndarc.med.unsw.edu.au/spotlightpresentatio...
The 2022 NDARC Annual Research Symposium was held online via Zoom on Tuesday, 20 and Wednesday, 21 September 2022. The Symposium showcased the work of leading national and international researchers in the alcohol and other drugs sector and related fields.
See the video presentations on the NDARC website:
- Saki Talukder - Inequity in smoking cessation clinical trials testing pharmacotherapies: exclusion of smokers with mental health disorders
- Thomas Santo Jr - Prevalence of mental disorders among people with opioid use disorder: A Systematic Review and Meta-analysis
- Dr Simon Clay - Incentivise: Client perceptions on contingency management as a treatment for methamphetamine dependency
- Olivia Price - COVID-19 vaccination among people in Australia who inject drugs: high uptake among an initially hesitant population
- Wing See Yuen - Age, period, and cohort effects on alcohol-related risky behaviour in Australia from 2001 to 2016
- Christel Macdonald - Who gets diverted into treatment? A study of defendants with psychosis
- Chrianna Bharat - The effect of opioid analgesics, benzodiazepines, gabapentinoids, and opioid agonist treatment on mortality risk among opioid-dependent people
B Substances > Tobacco (cigarette smoking)
B Substances > Opioids (opiates)
G Health and disease > State of health > Mental health
G Health and disease > Substance use disorder > Alcohol use disorder
G Health and disease > Substance use disorder > Drug use disorder
G Health and disease > Disease by cause (Aetiology) > Communicable / infectious disease > Viral disease / infection > Coronavirus (COVID-19)
G Health and disease > Behavioural and mental health disorder (Psychosis / mood)
HJ Treatment or recovery method > Substance disorder treatment method > Substance replacement method (substitution) > Opioid agonist treatment (methadone maintenance / buprenorphine)
J Health care, prevention, harm reduction and treatment > Treatment and maintenance > Treatment factors
L Social psychology and related concepts > Participation incentive / reward (contingency)
MM-MO Crime and law > Justice and enforcement system
T Demographic characteristics > Person who injects drugs (Intravenous / injecting)
T Demographic characteristics > Offender
VA Geographic area > Australia and Oceania > Australia
Repository Staff Only: item control page